Skip to main content
Equibles
QNCX logo

QNCX · Quince Therapeutics, Inc.

Track QNCX — free

Use QNCX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$32.96 -0.80 (-2.36%) At close · Aug 31
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$34.33M
Shares
1.02M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-12-29 LUCA BENATTI 50,000
Showing 1–1 of 1 filings
Key facts CIK 1662774 CUSIP 22053A305 13F (30d) 32 filings 28 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)